BVF PARTNERS L P/IL Insider Trading $ARQL ARQULE INC
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in ARQULE INC
Trading Symbol: ARQLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,682,669 shares
Current Value: $6,415,257
Latest Transaction: Jun 01 2018
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in ARQULE INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 5.00 | 175,813 | 879,083 | 771,305 | 947.1 K to 771.3 K (-18.56 %) |
Jun 01 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 5.00 | 312,266 | 1,561,361 | 3,186,044 | 3.5 M to 3.2 M (-8.93 %) |
Jun 01 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 5.00 | 547,860 | 2,739,355 | 4,682,669 | 5.2 M to 4.7 M (-10.47 %) |
Apr 20 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.10 | 217,256 | 673,494 | 947,118 | 1.2 M to 947.1 K (-18.66 %) |
Apr 20 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.10 | 808,449 | 2,506,192 | 3,498,310 | 4.3 M to 3.5 M (-18.77 %) |
Apr 20 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.10 | 1,204,668 | 3,734,471 | 5,230,529 | 6.4 M to 5.2 M (-18.72 %) |
Apr 06 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 2.90 | 214,336 | 621,574 | 1,164,374 | 1.4 M to 1.2 M (-15.55 %) |
Apr 06 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 2.90 | 817,611 | 2,371,072 | 4,306,759 | 5.1 M to 4.3 M (-15.96 %) |
Apr 06 2018 | ARQL | ARQULE INC | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 2.90 | 1,269,634 | 3,681,939 | 6,435,197 | 7.7 M to 6.4 M (-16.48 %) |
Page: 1